GATA3 and neoplasm: We found that GATA3 ChIP-seq peaks from the MCF7 ER+ breast cancer cell line were statistically significantly enriched in the set of tumor-specific enhancers linked to GATA3 in BRCA by TENET, as compared to all tumor-specific enhancers linked to genes or to all tumor-specific enhancers (Fisher exact test, adj.